All articles
2 article(s) foundESSENTIEL
This Week's Highlights — April 20–24, 2026
April 23, 2026
WORLD(United States/Biotech/Proteomics) – Alamar Biosciences completes its IPO on Nasdaq (ticker ALMR), with shares issued at $17 and a first trade at $22.6, valuing the precision proteomics company at roughly $1.5B. Powered by its proprietary NULISA
BIOTECH EXPRESS
Alamar Biosciences, Asahi Kasei, Aicuris Anti‑infective Cures, AstraZeneca, SynSmart, Amporin Pharmaceuticals
April 20, 2026
WORLD(United States/Biotech/Proteomics) – Alamar Biosciences completes its IPO on Nasdaq (ticker ALMR), with shares issued at $17 and an initial listing at $22.6, valuing the precision proteomics company at around $1.5 billion. Driven by its propriet
